Table 3.

OR and 95% CI for prostate cancer associated with SNVs in BTNL2 in European Americans

Cases (n = 1,155)Controls (n = 1,060)
Genotypen (%)n (%)ORa (95% CI)P
rs41441651
 CC1,129 (97.8)1,051 (99.2)1.00
 CT or TTb26 (2.3)9 (0.9)2.73 (1.27–5.87)0.010
rs28362675
 CC1,131 (97.9)1,051 (99.2)1.00
 CA or AAb24 (2.1)9 (0.9)2.52 (1.16–5.46)0.019
  • aAdjusted for age.

  • bOne case is homozygous variant for both SNVs; 22 cases and 9 controls are heterozygous for both SNVs.